68 studies found for:    graves
Show Display Options
Rank Status Study
21 Recruiting Radioactive Iodide Therapy for Pediatric Graves' Disease
Condition: Graves' Disease
Interventions: Radiation: RAI treatment;   Drug: ATD Group
22 Active, not recruiting Remission Induction and Sustenance in Graves' Disease 2
Conditions: Graves Disease;   Hyperthyroidism
Intervention: Other: Stop medication
23 Unknown  TSH Receptor Antibody Heterogeneity in Children and Adolescents With Graves' Disease
Condition: Graves' Disease
Intervention:
24 Completed Genetic Polymorphisms Associated With Cigarette Smoking and Risk of Graves’ Disease
Condition: Graves' Disease
Intervention:
25 Recruiting Assessing the Impact of the Early and Systematic Hormonal Replacement After Radio-isotopic Ablation of Graves'hyperthyroïdism on Quality of Life, Efficiency and Tolerance
Condition: Graves Disease (Basedow's Disease)
Interventions: Drug: the early prophylactic introduction of low dose of LT4 (50 µg/d) at 15 days post-ablation;   Drug: The initiation of LT4 as soon as the first biological signs of hypothyroidism.
26 Unknown  Phase II Randomized Controlled Study of Sequential Orbital Radiotherapy for Graves' Ophthalmopathy
Condition: Graves' Disease
Intervention: Procedure: Radiotherapy
27 Recruiting Early Levothyroxine Post Radioactive Iodine
Condition: Graves' Disease
Intervention: Drug: Levothyroxine
28 Completed Evaluation of Optimal Time of Methimazole Discontinuation Before Radio-iodine Therapy in Hyperthyroid Grave's Patients
Condition: Graves Disease
Intervention: Drug: Methimazole
29 Terminated Bromocriptine and Pentoxifylline in Ophthalmopathy Autoimmune Treatment
Condition: Graves Ophthalmopathy
Interventions: Drug: Methimazole;   Drug: Bromocriptine;   Drug: Pentoxifylline
30 Terminated A Safety and Tolerability Study of Otelixizumab in Thyroid Eye Disease
Condition: Graves Ophthalmopathy
Interventions: Drug: Otelixizumab - low dose;   Drug: Otelixizumab - medium low dose;   Drug: Otelixizumab - medium high dose;   Drug: Otelixizumab - high dose;   Drug: Otelixizumab;   Drug: Methylprednisolone
31 Completed Thyroid Treatment Trial
Condition: Graves Ophthalmopathy
Intervention: Drug: Intravenous Methylprednisolone + Oral Methotrexate vs Intravenous Methylprednisolone + Placebo
32 Not yet recruiting Prostaglandin F2-alpha Eye Drops in Thyroid Eye Disease (Bima Study)
Condition: Graves' Ophthalmopathy
Interventions: Drug: Bimatoprost;   Drug: Eye drop solution
33 Unknown  Application of Digital Infrared Thermal Imaging (DITI) in Graves' Disease
Condition: Graves' Disease
Intervention:
34 Recruiting Differential Diagnosis of STA-PSV in Thyrotoxicosis
Conditions: Thyrotoxicosis;   Peak Systolic Velocity of Superior Thyroid Artery;   Thyroiditis;   Graves Disease
Intervention:
35 Completed Morphometric Analysis of Orbital Structures in Graves´ Orbitopathy
Condition: Dysthyroid Orbitopathy
Intervention:
36 Unknown  Use of Botox in the Management of Thyroid Related Upper Eyelid Retraction
Condition: Graves Ophthalmopathy
Interventions: Drug: Botulinum Toxin Type A;   Drug: Saline injection
37 Completed Thyroid-Associated Ophthalmopathy Subtypes and Orbital Antibodies
Condition: Graves' Ophthalmopathy
Intervention: Drug: Carbimazole, radio-active iodine (I131)
38 Completed Antithyroid Drugs During Radioiodine Therapy
Conditions: Toxic Nodular Goitre;   Graves Disease
Intervention: Drug: Methimazole
39 Completed Block-replacement Therapy During Radioiodine Therapy
Conditions: Toxic Nodular Goitre;   Graves' Disease
Interventions: Drug: MTZ+LT4;   Drug: Methimazole
40 Completed rhTSH, Thyroid Size, and Radioiodine Therapy in Benign Goiter
Conditions: Benign Nontoxic and Toxic Goiter;   Graves' Disease
Intervention: Drug: Recombinant human thyrotropin (Thyrogen)

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years